Canadian Nanotechnology PDA Mission - September 23 - 27, 2019 - Sao Paulo, Brazil

Request for Expression of Interest

Global Affairs Canada through the Consulate General of Canada in São Paulo and the National Research Council Industrial Research Assistance Program (NRC-IRAP), will be pleased to receive your application to participate in the “Canadian Nanotechnology PDA Mission to Brazil”, which will take place from 23-27 September, 2019 in São Paulo, Brazil.

This initiative is ‎part of the NanoCanada trade mission organised during the Nano Trade Show in São Paulo.

Note that interested companies must apply no later than June 20th 2019.

Mission Objective

The Partnership Development Activity (PDA) mission will focus on introducing Canadian SMEs to potential Brazilian partners for industrial R&D collaboration specific to nanotechnology with applications to the biotechnology, medicine, pharmaceuticals and cosmetics sectors.

Examples of R&D collaboration being targeted include:

Canadian Delegate Profile

Canadian participants should meet the requirements below in order to benefit from this initiative:

Technology and products of particular interest in the Brazilian sector include applications for:

Mission Description

The Canadian Nanotechnology PDA Mission to Brazil will take place from September 23th to 27th, on the margins of the Nano Trade Show which is part of the Trade Show Analitica, an international show in the Biotechnology, Chemical and Analytical Industry.

Elements of the 4-day mission may include:

Why Brazil?

The Life Sciences sector in Brazil offers great opportunities, including in the subsectors of health biotech and pharmaceutical. Big players in the market, like Ache, Libbs, Eurofarma and Biolab have invested in the Research and Development of new healthcare products and in biotechnology experimentation and all have developed great initiatives in nanotechnology. This is also seen in the cosmetic sector, with leaders like Grupo Boticario and Natura, as they are taking advantage of the sustainable and fertile environment for nanotechnology in Brazil. The Brazilian government has invested in the development of professionals as well as in the creation of a network of 26 laboratories called SisNano. Within SisNano, 8 national laboratories are active mainly in nanotech and nanoscience. Brazil also has financial mechanisms that support R&D partnerships between private industry, research centers and academia.

Health BioTech: Brazil is well known for having strong areas of research and investment in industrial biotechnology, particularly with regards to cellulosic sugars, agribusiness and biofuels. While Brazil is valued as an important player for its investment, research and development (R&D) in these areas, there is a portion of its biotech market that is focused on human health. Brazil has more than 500 biotech companies dedicated to the development of new drugs (small molecules and biological), diagnostics, vaccines, cell therapy, regenerative medicine and tissue engineering, advanced methods of assisted reproductive technology, genetic and molecular testing, among other areas.

The latest figures on the health and biological biotech sectors in Brazil show an annual sale of BRL 438 million in 2016. Looking at the sector’s average growth over the past five years and considering the impact of the economic crisis and poor GDP performance in 2017, it was estimated that this sub-sector reached BRL 462 million in 2017, a 5% growth in comparison to the previous year.

Pharmaceutical: Brazil is ranked among the top ten largest pharmaceutical markets worldwide, actually the 8th and predicted to become 5th by 2021. According to Interfarma’s - Brazil’s Association of the Pharmaceutical Research Industry - 2017 report, the Brazilian pharmaceutical sector’s revenue in 2017 was estimated at BRL 85.35 billion, registering a growth of 13.10%. The local pharmaceutical market comprises nearly 400 companies, over 50,000 pharmacies and more than 500 distributors of pharmaceutical products. Opportunities for foreign companies are vast and include large local pharma companies looking to co-develop new medicines through technology transfer partnerships for drug production.

Additional Market Information

The total healthcare expenditure in Brazil accounts for approximately 9% of the GDP. What especially calls attention is the fact that private expenditure has continued to represent the bigger proportion in the 1990s, 2000s, and 2010s, accounting for 53% of the total expenditures, while serving only 25% of the total population. Nearly ¾ of Brazilian hospitals are private. In this regard, the Brazilian private healthcare sector offers greater opportunities for Canadian companies interested in expanding their current position in the market.

Financial support for Travel Costs

The Canadian International Innovation Program (CIIP) may provide financial support to eligible participants for 50% of all eligible expenses (see application process below) such as:

How to Apply for Participation

  1. Interested companies should request an application form from Marie-Hélène Béland (, Trade Commissioner (Innovation) at the Consulate General of Canada in São Paulo. A complete application form requesting additional information on your company,your technology and your interest in discussing possible R&D opportunities will be sent to you;
  2. Completed application forms are due no later than June 20th, 2019 to Marie-Hélène Béland (;
  3. The Consulate General of Canada in São Paulo and NRC-IRAP will select companies to participate in the mission. Selected applicants can expect to be notified no later than June 25th, 2019;
  4. Companies formally selected to participate in the mission will be invited to apply for travel funding support. Participants that have indicated their interest within the application form will receive the fund form from Marie-Hélène Béland;
  5. Companies who have applied for travel support can expect to be notified of the decision on travel funding supportno later than July 19th, 2019.

Please note: Participation is limited. Applications submitted will be assessed and vetted to determine the eligibility and the relevance of the Applicant to participate in the PDA based on the quality of the information provided in regards to the technology and the appropriateness of the technology for the target CIIP PDA market.

Canadian International Innovation Program (CIIP)

Global Affairs Canada (GAC) in collaboration with the National Research Council Industrial Research Assistance Program (NRC-IRAP) delivers the Canadian International Innovation Program (CIIP) in Brazil. CIIP supports industrial R&D collaborations between Canadian SMEs and companies in key markets, including Brazil. Collaborative R&D projects (validation, adaptation and co-development) between Canadian and Brazilian companies resulting from the Canadian Nanotechnology PDA Mission to Brazil may be eligible to apply for CIIP project funding in future.

Date Modified: